NCT04036877View on ClinicalTrials.gov

Mood Disorders Bladder Cancer

CompletedOBSERVATIONAL
Enrollment

358

Participants

Timeline

Start Date

September 19, 2019

Primary Completion Date

January 14, 2020

Study Completion Date

August 4, 2021

Conditions
Bladder Cancer
Interventions
OTHER

Mood Disorder Assessment

Assess depression, anxiety, HRQOL, and financial toxicity in both bladder cancer patients and their caregivers via telephone survey

Trial Locations (1)

66160

University of Kansas Health System, Kansas City

All Listed Sponsors
lead

University of Kansas Medical Center

OTHER

NCT04036877 - Mood Disorders Bladder Cancer | Biotech Hunter | Biotech Hunter